ADMEDUS LTD GETS FDA APPROVAL FOR LAUNCH OF VASCUCEL IN US

S&P ASX All Technology

3,966.40

0.06%

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ADMEDUS LTD GETS FDA APPROVAL FOR LAUNCH OF VASCUCEL IN US

/newsletter/barneyc/517/admedus-ltd-gets-fda-approval-for-launch-of-vascucel-in-us

Admedus (ASX:AHZ)
Historical Stock Chart
From Nov 2024 to Dec 2024

Admedus (ASX:AHZ)
Historical Stock Chart
From Dec 2023 to Dec 2024

News

Real-Time news about Admedus Limited (Australian Stock Exchange): 0 recent articles

Chart
Level 2
Trades
News
Financials

USOTC

TDOMF

Toronto Dominion Bank On... (PK)

Chart
Level 2
Trades
News
Financials

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

AHZ Admedus Limited

News

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

AHZ Admedus Limited

News

Your Recent History

Company

Business

Popular

Get The App

BLACK FRIDAY

Save up to 60%* for ASX Level 1 & 2

1 year 40%, 2 years 40% and *3 years 60%